Ignite Creation Date:
2025-12-24 @ 2:45 PM
Ignite Modification Date:
2025-12-26 @ 1:16 PM
Study NCT ID:
NCT00959959
Status:
COMPLETED
Last Update Posted:
2020-09-04
First Post:
2009-08-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancer
Sponsor:
LTN PHARMACEUTICALS, INC.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TOK-200-05
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None